Target
B-cell receptor CD22
Ligand
BDBM50556307
Substrate
n/a
Meas. Tech.
ChEMBL_2055847 (CHEMBL4710848)
Kd
335±n/a nM
Citation
 Abdu-Allah, HHMWu, SCLin, CHTseng, YY Design, synthesis and molecular docking study of ?-triazolylsialosides as non-hydrolyzable and potent CD22 ligands. Eur J Med Chem 208:0 (2020) [PubMed]  Article 
Target
Name:
B-cell receptor CD22
Synonyms:
CD22 | CD22_HUMAN | SIGLEC2
Type:
PROTEIN
Mol. Mass.:
95348.60
Organism:
Homo sapiens (Human)
Description:
ChEMBL_727026
Residue:
847
Sequence:
MHLLGPWLLLLVLEYLAFSDSSKWVFEHPETLYAWEGACVWIPCTYRALDGDLESFILFHNPEYNKNTSKFDGTRLYESTKDGKVPSEQKRVQFLGDKNKNCTLSIHPVHLNDSGQLGLRMESKTEKWMERIHLNVSERPFPPHIQLPPEIQESQEVTLTCLLNFSCYGYPIQLQWLLEGVPMRQAAVTSTSLTIKSVFTRSELKFSPQWSHHGKIVTCQLQDADGKFLSNDTVQLNVKHTPKLEIKVTPSDAIVREGDSVTMTCEVSSSNPEYTTVSWLKDGTSLKKQNTFTLNLREVTKDQSGKYCCQVSNDVGPGRSEEVFLQVQYAPEPSTVQILHSPAVEGSQVEFLCMSLANPLPTNYTWYHNGKEMQGRTEEKVHIPKILPWHAGTYSCVAENILGTGQRGPGAELDVQYPPKKVTTVIQNPMPIREGDTVTLSCNYNSSNPSVTRYEWKPHGAWEEPSLGVLKIQNVGWDNTTIACAACNSWCSWASPVALNVQYAPRDVRVRKIKPLSEIHSGNSVSLQCDFSSSHPKEVQFFWEKNGRLLGKESQLNFDSISPEDAGSYSCWVNNSIGQTASKAWTLEVLYAPRRLRVSMSPGDQVMEGKSATLTCESDANPPVSHYTWFDWNNQSLPYHSQKLRLEPVKVQHSGAYWCQGTNSVGKGRSPLSTLTVYYSPETIGRRVAVGLGSCLAILILAICGLKLQRRWKRTQSQQGLQENSSGQSFFVRNKKVRRAPLSEGPHSLGCYNPMMEDGISYTTLRFPEMNIPRTGDAESSEMQRPPPDCDDTVTYSALHKRQVGDYENVIPDFPEDEGIHYSELIQFGVGERPQAQENVDYVILKH
  
Inhibitor
Name:
BDBM50556307
Synonyms:
CHEMBL4788433
Type:
Small organic molecule
Emp. Form.:
C33H34N5NaO10
Mol. Mass.:
683.6403
SMILES:
[Na;v0+].[H][C@]1([#8][C@]([#6]-[#6@H](-[#8])-[#6@H]1-[#7]-[#6](=O)-[#6]-[#8])([#6](-[#8-])=O)n1cc(nn1)-c1ccccc1)[#6@H](-[#8])-[#6@H](-[#8])-[#6]-[#7]-[#6](=O)-[#6]-c1ccc(cc1)-c1ccc(-[#8])cc1 |r|
Structure:
Search PDB for entries with ligand similarity: